Cover Image

Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach

Hydroxychloroquine (HCQ), a congener of chloroquine, is widely used in prophylaxis and the treatment of malaria, and also as a cure for rheumatoid arthritis, systemic lupus erythematosus, and various other diseases. Physiologically based pharmacokinetic modeling (PBPK) has attracted great interest i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Faleh Alqahtani (Author), Ali Mohammed Asiri (Author), Ammara Zamir (Author), Muhammad Fawad Rasool (Author), Amer S. Alali (Author), Sary Alsanea (Author), Ismail A. Walbi (Author)
Format:	Book
Published:	MDPI AG, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023)

Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations
by: Hafsa Hafsa, et al.
Published: (2022)

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations
by: Mohammed S. Alasmari, et al.
Published: (2022)

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment
by: Mahnoor Pasha, et al.
Published: (2024)

The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia
by: Ismail A. Walbi, et al.
Published: (2022)

A Physiologically Based Pharmacokinetic Model to Predict Systemic Ondansetron Concentration in Liver Cirrhosis Patients
by: Faleh Alqahtani, et al.
Published: (2023)

Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: a tool for model-informed precision dosing
by: Fawaz Alasmari, et al.
Published: (2023)

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia
by: Samia Kalsoom, et al.
Published: (2024)

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
by: Sundus Khalid, et al.
Published: (2021)

Complete clearance of cutaneous warts with hydroxychloroquine: Antiviral action?
by: Premanshu Bhushan, et al.
Published: (2014)

Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
by: Basile Amice, et al.
Published: (2021)

Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations
by: Muhammad F. Rasool, et al.
Published: (2019)

Pharmacokinetic profile of sildenafil citrate in healthy Middle Eastern Males: Comparison with other ethnicities
by: Abdulrahman Alwhaibi, et al.
Published: (2021)

A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS‐CoV‐2(−)/(+) populations
by: Claire Steinbronn, et al.
Published: (2023)

Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance
by: Khaled Abduljalil, et al.
Published: (2024)

Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling
by: Cindy H. T. Yeung, et al.
Published: (2023)

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
by: Johanna Weiss, et al.
Published: (2020)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
by: Miao Zhang, et al.
Published: (2021)

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model
by: Jianling Yang, et al.
Published: (2020)

Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
by: Memoona Rashid, et al.
Published: (2020)

Predicting complex kidney drug handling using a physiologically‐based pharmacokinetic model informed by biomarker‐estimated secretory clearance and blood flow
by: Michael L. Granda, et al.
Published: (2024)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020)

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
by: Jean Claude Alvarez, et al.
Published: (2022)

6. EXERCISE PHYSIOLOGY AND PATHOPHYSIOLOGY OF LACTATE ACIDOSIS AND CLEARANCE
Published: (2020)

Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance
by: Weize Huang, et al.
Published: (2018)

Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers
by: Kosuke Yoshida, et al.
Published: (2022)

Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs
by: Reza Mehvar
Published: (2018)

Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
by: Yang Chu, et al.
Published: (2020)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
by: Bin Du, et al.
Published: (2021)

Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
by: Zakariya Kashour, et al.
Published: (2021)

Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients
by: Kalam MN, et al.
Published: (2021)

Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics
by: Myongjae Lee, et al.
Published: (2022)

Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method
by: Qi Liu, et al.
Published: (2021)

Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique
by: Amer S. AlAli, et al.
Published: (2021)

Population pharmacokinetics of gentamicin in acute lymphoblastic leukemia pediatric patients compared to non-oncology patients
by: Hisham S. Abou-Auda, et al.
Published: (2024)

Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model
by: Flavia Storelli, et al.
Published: (2024)

Hyperpigmentation Induced by Hydroxychloroquine
by: Laila Hamri
Published: (2023)

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions
by: Stefan Willmann, et al.
Published: (2021)